World's Best Scientists 2026 revealed!
Award Badge
Immunology
USA
2025

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Immunology 140 165 152 110 101 1078 64984
Medicine 141 1634 1512 950 869 1404 70756

David M. Goldenberg publications per year

The chart shows the history of publications by David M. Goldenberg between 1966 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. David M. Goldenberg published across 60 years, from 1966 to 2025, averaging 31.9 papers a year. Output peaked at 237 publications in 2023. 120 of the 1,911 publications appeared in the last two years.

No. of publications
50 100 150 200
Bar chart. Horizontal axis: year, 1966 to 2025. Vertical axis: number of publications, 0 to 237. Peak 237 publications in 2023. 1966: 1 publication 1967: 0 publications 1968: 1 publication 1969: 0 publications 1970: 1 publication 1971: 1 publication 1972: 2 publications 1973: 2 publications 1974: 4 publications 1975: 4 publications 1976: 6 publications 1977: 7 publications 1978: 9 publications 1979: 3 publications 1980: 18 publications 1981: 10 publications 1982: 9 publications 1983: 9 publications 1984: 6 publications 1985: 5 publications 1986: 4 publications 1987: 7 publications 1988: 15 publications 1989: 14 publications 1990: 31 publications 1991: 18 publications 1992: 22 publications 1993: 14 publications 1994: 40 publications 1995: 26 publications 1996: 24 publications 1997: 41 publications 1998: 15 publications 1999: 39 publications 2000: 36 publications 2001: 20 publications 2002: 22 publications 2003: 42 publications 2004: 37 publications 2005: 51 publications 2006: 48 publications 2007: 47 publications 2008: 48 publications 2009: 58 publications 2010: 60 publications 2011: 146 publications 2012: 70 publications 2013: 57 publications 2014: 48 publications 2015: 69 publications 2016: 49 publications 2017: 48 publications 2018: 19 publications 2019: 16 publications 2020: 26 publications 2021: 31 publications 2022: 98 publications 2023: 237 publications 2024: 100 publications 2025: 20 publications
1966 2025

1,911 publications in total across all disciplines

View publications per year as a table
David M. Goldenberg: publications per year, 1966 to 2025
Year Publications
1966 1
1967 0
1968 1
1969 0
1970 1
1971 1
1972 2
1973 2
1974 4
1975 4
1976 6
1977 7
1978 9
1979 3
1980 18
1981 10
1982 9
1983 9
1984 6
1985 5
1986 4
1987 7
1988 15
1989 14
1990 31
1991 18
1992 22
1993 14
1994 40
1995 26
1996 24
1997 41
1998 15
1999 39
2000 36
2001 20
2002 22
2003 42
2004 37
2005 51
2006 48
2007 47
2008 48
2009 58
2010 60
2011 146
2012 70
2013 57
2014 48
2015 69
2016 49
2017 48
2018 19
2019 16
2020 26
2021 31
2022 98
2023 237
2024 100
2025 20
Total 1,911
Download as CSV

David M. Goldenberg publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where David M. Goldenberg sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 76 bars. Horizontal axis: publications, 62–71 to 807+. Vertical axis: number of scientists, 0 to 189. Most scientists, 189, have 152–161 publications. The last bar groups every scientist with 807 publications or more. The highlighted bar, 807+ publications, is where this scientist sits. 62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientist 807+ publications: 100 scientists
62–71 publications 807+

This scientist: 1,078 publications — 99th percentile

99% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

View publications distribution as a table
Number of Immunology scientists by publication count, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
Publications Scientists This scientist
62–71 9
72–81 23
82–91 40
92–101 72
102–111 86
112–121 108
122–131 150
132–141 160
142–151 159
152–161 189
162–171 166
172–181 181
182–191 188
192–201 187
202–211 178
212–221 158
222–231 168
232–241 159
242–251 160
252–261 148
262–271 116
272–281 125
282–291 115
292–301 111
302–311 95
312–321 97
322–331 97
332–341 99
342–351 96
352–361 69
362–371 76
372–381 71
382–391 71
392–401 62
402–411 54
412–421 41
422–431 63
432–441 53
442–451 31
452–461 42
462–471 40
472–481 29
482–491 34
492–501 30
502–511 23
512–521 41
522–531 29
532–541 28
542–551 16
552–561 18
562–571 18
572–581 17
582–591 17
592–601 17
602–611 19
612–621 13
622–631 12
632–641 11
642–651 16
652–661 9
662–671 5
672–681 13
682–691 12
692–701 6
702–711 6
712–721 9
722–731 9
732–741 6
742–751 11
752–761 10
762–771 7
772–781 12
782–791 7
792–801 5
802–806 1
807+ 100 1,078
Download as CSV

David M. Goldenberg D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where David M. Goldenberg sits on this spectrum.

No. of scientists
50 100 150 200
Bar chart with 60 bars. Horizontal axis: D-Index, 40–41 to 157+. Vertical axis: number of scientists, 0 to 201. Most scientists, 201, have 58–59 D-Index. The last bar groups every scientist with 157 D-Index or more. The highlighted bar, 140–141 D-Index, is where this scientist sits. 40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40–41 D-Index 157+

This scientist: 140 D-Index — 97th percentile

97% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

View D-Index distribution as a table
Number of Immunology scientists by D-index, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
D-Index Scientists This scientist
40–41 28
42–43 91
44–45 157
46–47 192
48–49 175
50–51 188
52–53 177
54–55 155
56–57 194
58–59 201
60–61 197
62–63 201
64–65 173
66–67 167
68–69 172
70–71 199
72–73 184
74–75 133
76–77 163
78–79 127
80–81 121
82–83 125
84–85 121
86–87 102
88–89 96
90–91 75
92–93 72
94–95 74
96–97 66
98–99 68
100–101 49
102–103 60
104–105 54
106–107 36
108–109 23
110–111 52
112–113 41
114–115 34
116–117 25
118–119 28
120–121 11
122–123 20
124–125 27
126–127 19
128–129 20
130–131 16
132–133 17
134–135 14
136–137 15
138–139 9
140–141 11 140
142–143 9
144–145 9
146–147 7
148–149 7
150–151 7
152–153 5
154–155 8
156 6
157+ 96
Download as CSV

Research.com Recognitions

  • 2025 - Research.com Immunology in United States Leader Award

Overview

David M. Goldenberg is affiliated with Immunomedics in the United States and has a substantial publication record in the field of Medicine, with a particular focus on Oncology. Their research spans several subfields including Oncology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, Surgery, and Epidemiology.

The scientist's work addresses key topics such as:

  • HER2/EGFR in Cancer Research
  • Radiopharmaceutical Chemistry and Applications
  • Cancer Treatment and Pharmacology
  • Advanced Breast Cancer Therapies
  • LGBTQ Health, Identity, and Policy
  • Tracheal and airway disorders
  • Colorectal Cancer Treatments and Studies

David M. Goldenberg has contributed to multiple publications in prominent venues, including:

  • Annals of Oncology
  • Cancer Research
  • Oncotarget
  • npj Breast Cancer
  • Journal of Nuclear Medicine

The scientist has collaborated frequently with several co-authors, such as Robert T. Sataloff, Robert M. Sharkey, Edward Fisher, Ehab Y. Hanna, and Jonas T. Johnson.

Selected recent papers authored or co-authored by David M. Goldenberg include:

  • Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer, 2021, New England Journal of Medicine
  • Sacituzumab govitecan, a Trop-2-directed antibody-drug conjugate, for patients with epithelial cancer: final safety and efficacy results from the phase I/II IMMU-132-01 basket trial, 2021, Annals of Oncology
  • Biomarker analyses in the phase III ASCENT study of sacituzumab govitecan versus chemotherapy in patients with metastatic triple-negative breast cancer, 2021, Annals of Oncology
  • Sacituzumab govitecan in previously treated hormone receptor-positive/HER2-negative metastatic breast cancer: final results from a phase I/II, single-arm, basket trial, 2020, Annals of Oncology
  • Sacituzumab govitecan, a novel, third-generation, antibody-drug conjugate (ADC) for cancer therapy, 2020, Expert Opinion on Biological Therapy

Best Publications

  • Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer

    Aditya Bardia;Sara A Hurvitz;Sara M Tolaney;Delphine Loirat

  • Use of Radiolabeled Antibodies to Carcinoembryonic Antigen for the Detection and Localization of Diverse Cancers by External Photoscanning

    D.M. Goldenberg;F. DeLand;E. Kim;S. Bennett

  • Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer.

    Aditya Bardia;Ingrid A Mayer;Linda T Vahdat;Sara M Tolaney

  • Trop-2 is a novel target for solid cancer therapy with sacituzumab govitecan (IMMU-132), an antibody-drug conjugate (ADC)

    David M. Goldenberg;Thomas M. Cardillo;Serengulam V. Govindan;Edmund A. Rossi

  • Ionization−Reactivity Relationships for Cysteine Thiols in Polypeptides†

    Grzegorz Bulaj;Tanja Kortemme;David P. Goldenberg

  • CYSTIC LYMPH NODE METASTASIS IN PATIENTS WITH HEAD AND NECK CANCER: AN HPV-ASSOCIATED PHENOMENON

    David Goldenberg;Shahnaz Begum;William H. Westra;Zubair Khan

  • Immunotherapy of B-cell malignancies using anti-CD22 antibodies

    David M. Goldenberg

  • A Novel Method of 18F Radiolabeling for PET

    William J. McBride;Robert M. Sharkey;Habibe Karacay;Christopher A. D'Souza

  • Targeted Therapy of Cancer with Radiolabeled Antibodies

    David M Goldenberg

  • Efficacy and Safety of Anti-Trop-2 Antibody Drug Conjugate Sacituzumab Govitecan (IMMU-132) in Heavily Pretreated Patients With Metastatic Triple-Negative Breast Cancer.

    Aditya Bardia;Ingrid A. Mayer;Jennifer R. Diamond;Rebecca L. Moroose

  • Oral complications of radiotherapy.

    James J Sciubba;David Goldenberg

  • Antibody Pretargeting Advances Cancer Radioimmunodetection and Radioimmunotherapy

    David M. Goldenberg;Robert M. Sharkey;Giovanni Paganelli;Jacques Barbet

  • Radioimmunodetection of cancer with radioactive antibodies to carcinoembryonic antigen

    D M Goldenberg;E E Kim;F H DeLand;S Bennett

  • First-in-Human Trial of a Novel Anti-Trop-2 Antibody-SN-38 Conjugate, Sacituzumab Govitecan, for the Treatment of Diverse Metastatic Solid Tumors.

    Alexander N. Starodub;Allyson J. Ocean;Manish A. Shah;Michael J. Guarino

  • Kinetic role of a meta-stable native-like two-disulphide species in the folding transition of bovine pancreatic trypsin inhibitor☆

    T.E. Creighton;D.P. Goldenberg

  • Stably tethered multifunctional structures of defined composition made by the dock and lock method for use in cancer targeting

    Edmund A. Rossi;David M. Goldenberg;Thomas M. Cardillo;William J. McBride

  • Initial clinical trial of epratuzumab (humanized anti-CD22 antibody) for immunotherapy of systemic lupus erythematosus.

    Thomas Dörner;Joerg Kaufmann;William A Wegener;Nick Teoh

  • Reducing the renal uptake of radiolabeled antibody fragments and peptides for diagnosis and therapy: present status, future prospects and limitations

    Thomas M. Behr;David M. Goldenberg;Wolfgang Becker

  • Humanized Anti-Trop-2 IgG-SN-38 Conjugate for Effective Treatment of Diverse Epithelial Cancers: Preclinical Studies in Human Cancer Xenograft Models and Monkeys

    Thomas M. Cardillo;Serengulam V. Govindan;Robert M. Sharkey;Preeti Trisal

  • Expression patterns of CEACAM5 and CEACAM6 in primary and metastatic cancers

    Rosalyn D Blumenthal;Evelyn Leon;Hans J Hansen;David M Goldenberg

  • Tracheotomy Complications: A Retrospective Study of 1130 Cases:

    David Goldenberg;Eliav Gov Ari;Avishay Golz;Joshua Danino

  • Epratuzumab, a humanized anti-CD22 antibody, in aggressive non-Hodgkin's lymphoma: phase I/II clinical trial results.

    John P. Leonard;Morton Coleman;Jamie C. Ketas;Amy Chadburn

Frequent Co-Authors

Robert M. Sharkey
Robert M. Sharkey University of Fukui
Chien-Hsing Chang
Chien-Hsing Chang Northwestern University
Hans J. Hansen
Hans J. Hansen Eisai (Japan)
Edmund A. Rossi
Edmund A. Rossi Immunomedics (United States)
Gary L. Griffiths
Gary L. Griffiths National Institutes of Health
Otto C. Boerman
Otto C. Boerman Radboud University
Wim J.G. Oyen
Wim J.G. Oyen Humanitas University
Ivan D. Horak
Ivan D. Horak Freie Universität Berlin
Jacques Barbet
Jacques Barbet University of Nantes
Aditya Bardia
Aditya Bardia Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in immunology often intersects with various healthcare and nursing pathways. For those interested in expanding their qualifications quickly, exploring accelerated np programs can be a strategic move. These programs offer an efficient route for nurses aiming to become Nurse Practitioners, allowing them to deepen their clinical expertise and impact in immunology-related fields.

If you don’t have a nursing background but wish to enter this domain, consider enrolling in online bsn programs for non nurses. These programs help non-nurses acquire foundational nursing knowledge, which is crucial for immunology research and patient care roles.

For quicker entry into nursing alongside immunology interests, candidates often look for accelerated nursing programs near me. These are designed to fast-track your education, enabling a faster transition into the workforce.

Additionally, accredited lpn programs easy to get into provide foundational nursing credentials and serve as a stepping stone for further specialization relevant to immunology careers.

Best Scientists Citing David M. Goldenberg

Trending Scientists

Recently Published Articles